News Spectre of 'favoured nation' pricing manifests again in US President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas.
News FDA ramps up unannounced inspections of foreign facilities Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.
News Can other countries entice US scientists hit by Trump cuts? The UK is said to be preparing a £50m scheme to attract top scientific talent from other countries, including US teams facing big funding cuts.
News Senior Republican hits out at Trump's research funding cuts The Republican chair of the Appropriations Committee has slammed the Trump administration for actions that are putting US biomedical research at risk.
News NEJM responds to claims of bias from Justice Department The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr.
News Roche joins the pharma firms planning big US investments Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.